Stocks move up and stocks move down. Expectations vary likewise. In FPH's case I think the SP got a bit beyond expectations and is adjusting, short term, accordingly.
Disc. Holding.
Printable View
Long term they have manufacturing capacity & only touching 10-15 % of their potential market.
Covid is helping not just short term COVID related sales but long term for clinicians to realize the benefits on patient recovery for other conditions as well.
https://www.fphcare.com/in/hospital/...ation/nivairo/
https://www.fphcare.com/in/hospital/...tory/optiflow/
https://www.fphcare.com/in/hospital/...ical-outcomes/
https://www.marketscreener.com/quote...30/financials/
[QUOTE=kiora;858203]Long term they have manufacturing capacity & only touching 10-15 % of their potential market.
Covid is helping not just short term COVID related sales but long term for clinicians to realize the benefits on patient recovery for other conditions as well.
https://www.fphcare.com/in/hospital/...ation/nivairo/
https://www.fphcare.com/in/hospital/...tory/optiflow/
https://www.fphcare.com/in/hospital/...ical-outcomes/
https://www.marketscreener.com/quote...30/financials/[/QUOTE
Its been on the UNDERPERFORM list of many brokerages for very long still it keeps performing alright . Its expensive multiples make many think its not a buy . Still buying keeps happening !!
What can be the main reasons for that ? ETF or Passive NZ index holders need have 16.15 % of FPH and there are lots of investments in those kind of funds !
Covid benefactor FPH did very well in last 9 months ...so what next ...give back part gains or move sideways for long till further non covid growth catches up ?
Covid has pushed its NP and revenue ahead by at least 18 months so next 18 months further growth not easy to come ...maybe the reason all have underperform rating on this stock ?
FPH future can be little difficult to judge in the next 12-24 months ....maximum a Hold
alokdhir
Did you check the link to the marketscreener forecasts?
Sales etc expected to level off 2022 then start rising again
I've been invested in FPH for about 10 years, I think. I can not think of a time during that decade when most people have not thought it was overpriced. I originally bought in at around $4.25 and people were saying it was overpriced back then and I thought so too on all the metrics I normally use. I've given up on this one and now just say it should be an essential part of any long term portfolio on the NZX. I only say that about FPH and MFT.
Yes I checked all forecasts and also consensus targets also . Thats why the question that for next 12 months it will move side ways or further down . I did a most likely scenario that it can drop further 10 % ie maximum downside to $ 30 and upside of $ 40 in the next 12 months . That makes it a Hold for me maximum .
FPH is one of only two stocks in NZ that I've never had to worry about. First bought in 2008 and have sold parcels over the years just because the position got too big.
All have good stories of this stock . All know its most rewarding too . All agree its super expensive compared to others . Maybe its the best thats why its most expensive too . Pay extra for quality .
I am really looking forward to what they will say about future at HY results on Wednesday . As they are always conservative in future assessment and almost always exceed their guidance by a small margin even after upgrading it little before the results . Market respects their guidance . So it will shed some very welcome light on their immediate future prospects
If they need to further increase FY prospects that will be great . Which is the most likely case IMHO
Vaccine news have come as a short term blow to its SP , maybe actual results and future guidance will reverse that pessimism ?
Wowza...... great result. See here.
Net Profit up 86%
Well done holders!!